Related Experiment Videos
[Opportunistic diseases. Risk can be estimated]
1Medizinische Klinik, Infektionsambulanz, Klinikum Salzgitter.
MMW Fortschritte Der Medizin
|March 12, 2004
Summary
Opportunistic diseases are increasing in HIV patients, even with treatment. Hospitalizations now include medication side effects and liver issues, with rising mortality rates observed since 1999.
Area of Science:
- Infectious Diseases
- Immunology
- Public Health
Context:
- The incidence of opportunistic diseases in clinical practice is increasing.
- Highly active antiretroviral therapy (HAART) has altered the disease spectrum in HIV patients.
- Trends observed since 2000 indicate a resurgence in certain opportunistic infections.
Purpose:
- To highlight the changing landscape of opportunistic diseases in HIV patients.
- To discuss the role of CD4 cell count and viral burden in predicting infection risk.
- To examine the impact of HAART on hospitalization patterns and mortality.
Summary:
- Opportunistic diseases are becoming more prevalent in daily clinical settings.
- Cytomegalovirus (CMV) viremia can predict outcomes when HAART is ineffective.
- Hospitalizations are increasingly due to medication toxicity, respiratory infections, and hepatitis.
- Despite initial decreases, HIV patient mortality rates have risen since 1999.
Impact:
- This research underscores the need for continued vigilance and adaptation in managing HIV care.
- Understanding these shifts is crucial for optimizing treatment strategies and patient outcomes.
- The findings emphasize the evolving challenges in controlling opportunistic infections and managing long-term HIV complications.